rsodeoxycholic Acid in Morbidly Obese Patients Before Bariatric Surgery - UrsoObese
- Conditions
- Patients with morbid obesity (MB) are investigated. MB is very frequently (90%) associated with non-alcoholic fatty liver disease (NAFLD) comprising a spectrum reaching from steatosis (NAFL) over steatohepatitis (NASH) to fibrosis/cirrhosis.MedDRA version: 9.1Level: LLTClassification code 10029530Term: Non-alcoholic fatty liver
- Registration Number
- EUCTR2007-005531-28-SE
- Lead Sponsor
- Hanns-Ulrich Marschall
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Morbidly obese (BMI >35 kg/m2) patients of both gender scheduled for bariatric surgery.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years)
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Any condition that does not allow bariatric surgery, i.e. major cardiovascular, liver or kidney disease, pregnancy, drug abuse.
Insulin-dependent or independent diabetes mellitus.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method